Recursion Pharmaceuticals (NASDAQ: RXRX)
Recursion Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Recursion Pharmaceuticals Company Info
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
News & Analysis
Why Recursion Pharmaceuticals Stock Tanked on Tuesday
It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.
Recursion (RXRX) Q2 Revenue Jumps 33%
Why Recursion Pharmaceuticals Stock Got Mashed on Monday
Investors weren't cheered by news from one of the biotech's rivals.
Here's Why Shares in Recursion Pharmaceuticals Surged Today
5 of the Best AI ETFs to Buy Now
There are several options for investors looking to diversify into AI.
Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?
Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday
How AI Is Used in Healthcare
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.